Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-843
Closed -$32.5K 393
2024
Q2
$32.5K Buy
843
+292
+53% +$12.3K 0.01% 288
2024
Q1
$23.6K Buy
551
+334
+154% +$13.8K 0.01% 294
2023
Q4
$8.04K Buy
217
+137
+171% +$4.92K ﹤0.01% 448
2023
Q3
$2.9K Hold
80
﹤0.01% 591
2023
Q2
$2.85K Hold
80
﹤0.01% 631
2023
Q1
$2.85K Sell
80
-271
-77% -$9.48K ﹤0.01% 462
2022
Q4
$12.3K Buy
+351
New +$11.7K 0.01% 360

Other funds holding GSK

RFP Financial Group's GSK Position: Q3 2024 in Review

RFP Financial Group sold out of GSK (GSK) in Q3 2024, closing a stake of 843 shares — an estimated $32.5K sold.

RFP Financial Group first reported a position in GSK in Q4 2022 and held it in 7 quarters. The position peaked at $32.5K in Q2 2024. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • RFP Financial Group reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 843 GSK shares in Q3 2024, an estimated $32.5K.
  • RFP Financial Group first reported a position in GSK in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's GSK position peaked at $32.5K in Q2 2024.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.